HIGHLIGHTS
SUMMARY
Clinical evaluation of DASH for SARS-CoV-2 infection Study design, population and recruitment The authors performed a cross-sectional study from June to September 2021 of adult (18 years and older) participants with or without symptoms of COVID-19 who were tested for SARS-CoV-2 at one of four outpatient clinical sites. Under the enhanced recruitment, the authors allowed for enrollment of individuals within seven days of testing positive for SARS-CoV-2 by a PCR-based assay. If DASH and Xpert testing were discordant, then if residual VTM from Xpert testing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.